CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation

Effective vaccine adjuvants must induce expression of major histocompatability (MHC) class II proteins and the costimulatory molecule CD86 on dendritic cells (DCs). However, some adjuvants elicit production of cytokines resulting in adverse inflammatory consequences. Development of agents that selec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tze, Lina E., Horikawa, Keisuke, Domaschenz, Heather, Howard, Debbie R., Roots, Carla M., Rigby, Robert J., Way, David A., Ohmura-Hoshino, Mari, Ishido, Satoshi, Andoniou, Christopher E., Degli-Esposti, Mariapia A., Goodnow, Christopher C.
Format: Artigo
Idioma:Inglês
Publicat: The Rockefeller University Press 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3023131/
https://ncbi.nlm.nih.gov/pubmed/21220452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20092203
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars